CHAI (CHAI) Stock Price & Analysis
CHAI (CHAI) fell 26.34% to USD 1.37 as of June 11, 2026 at 13:05 UTC, according to Nexqual real-time market data.
CHAI last closed at USD 1.86; the session ranged USD 1.2–1.59 on volume of 6,865,050 shares. Market capitalization is $27.29M, with a 52-week range of USD 0.8–20.72 (NCM). Source: Nexqual, June 11, 2026 at 13:05 UTC.
Key Statistics (as of June 11, 2026 at 13:05 UTC)
| Price | USD 1.37 |
|---|---|
| Change | ▼ 26.34% (down) |
| Previous Close | USD 1.86 |
| Open | USD 1.36 |
| Day Range | USD 1.2 – 1.59 |
| 52-Week Range | USD 0.8 – 20.72 |
| Volume | 6,865,050 shares |
| Market Cap | $27.29M |
| Exchange | NCM |
Technical Analysis (CHAI)
Nexqual's technical model rates CHAI "STRONG BUY" based on 6 bullish and 0 bearish signals across 124 daily candles, as of June 11, 2026 at 13:05 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 57.15 (neutral) |
| vs SMA50 | Above (USD 1.11) |
| MACD | 0.02 (positive) |
Analyst Ratings (CHAI)
Wall Street analysts rate CHAI "None", per Nexqual as of June 11, 2026 at 13:05 UTC.
| Consensus Rating | None |
|---|
Earnings (CHAI)
Source: Nexqual, June 11, 2026 at 13:05 UTC.
Financials & Fundamentals (CHAI)
| Total Revenue | $55.24M |
|---|---|
| Gross Margin | -0.55% |
| Operating Margin | -12.75% |
| Profit Margin | -57.19% |
| ROE | -272.05% |
| Debt / Equity | 5.24 |
| Current Ratio | 1.24 |
| Total Cash | $1.93M |
| Total Debt | $162,610 |
| Free Cash Flow | $-8.36M |
Source: Nexqual, June 11, 2026 at 13:05 UTC.
Financial Health Score (CHAI)
Nexqual rates CHAI's overall financial health "Weak" across five dimensions, as of June 11, 2026 at 13:05 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Critical — Gross margin -1%, operating -13% |
| Balance Sheet | Strong — $2M cash, no debt |
| Cash Flow | Weak — FCF negative: -$8M, burning cash |
| Efficiency | Critical — ROE -272%, ROA -26.7% |
Ownership (CHAI)
| Insider Ownership | +64.89% |
|---|---|
| Institutional Ownership | +0.58% |
| Shares Outstanding | 19.92M |
| Float | 5.37M |
| Short % of Float | +0.80% |
Source: Nexqual, June 11, 2026 at 13:05 UTC.
Leadership (CHAI)
CHAI is led by Aitan Zacharin (age 42), CEO & Chairman, per Nexqual as of June 11, 2026 at 13:05 UTC.
| CEO & Chairman | Aitan Zacharin (age 42) |
|---|---|
| Chief Financial Officer | Gerald Bernstein (age 61) |
Major Backers & Investors (CHAI)
Notable institutional backers of CHAI include FNY Investment Advisers, LLC, Citadel, according to Nexqual as of June 11, 2026 at 13:05 UTC.
Active Investors
| Investor | Stake |
|---|---|
| FNY Investment Advisers, LLC | 0.17% |
| Citadel | 0.11% |
Source: Nexqual, June 11, 2026 at 13:05 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ENSC | Ensysce Biosciences, Inc. | USD 0.25 | ▲ 0.4% |
| DBGI | Digital Brands Group, Inc. | USD 1.25 | ▲ 26.26% |
| ADTX | Aditxt, Inc. | USD 0.02 | ▼ 63% |
| PTPI | Petros Pharmaceuticals, Inc. | USD 0.01 | ▲ 16.67% |
| KTTA | Pasithea Therapeutics Corp. | USD 0.58 | ▲ 0.69% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 11, 2026 at 13:05 UTC. This page is informational and not investment advice.